Back
Aldeyra Therapeutics Vs. Esperion Therapeutics Industry Stock Comparison
Buy
56
ALDX
Aldeyra Therapeutics
Last Price:
4.16
Seasonality Move:
7.79%
Sell
31
ESPR
Esperion Therapeutics
Last Price:
2.09
Seasonality Move:
-9.97%
Buy
56
Aldeyra Therapeutics (ALDX)
is a Buy
Is Aldeyra Therapeutics a Buy, Sell or Hold?
- The current Aldeyra Therapeutics [ALDX] share price is $4.16. The Score for ALDX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ALDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy, Sell or Hold?
- The current Esperion Therapeutics [ESPR] share price is $2.08. The Score for ESPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- ESPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALDX Stock Price Chart
What is Aldeyra Therapeutics's stock price today?
-
The Aldeyra Therapeutics share price today is $4.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALDX is experiencing slight selling pressure.
ESPR Stock Price Chart
What is Esperion Therapeutics's stock price today?
-
The Esperion Therapeutics share price today is $2.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESPR is experiencing selling pressure, which indicates risk of future bearish movement.
ALDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 57.92 | Buy |
Chaikin Money Flow: | -66892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.78 - 4.4) | Buy |
Bollinger Bands (100): | (3.02 - 3.96) | Buy |
ESPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 45.71 | Sell |
Chaikin Money Flow: | -2621622 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.76) | Sell |
Bollinger Bands (100): | (1.98 - 2.76) | Sell |
ALDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.05 | Buy |
20-day SMA: | 4.09 | Buy |
50-day SMA: | 3.71 | Buy |
200-day SMA: | 4.35 | Sell |
8-day EMA: | 4.08 | Buy |
20-day EMA: | 3.99 | Buy |
50-day EMA: | 3.78 | Buy |
200-day EMA: | 4.4 | Sell |
ESPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.02 | Buy |
20-day SMA: | 2.12 | Sell |
50-day SMA: | 2.34 | Sell |
200-day SMA: | 1.8 | Buy |
8-day EMA: | 2.04 | Buy |
20-day EMA: | 2.13 | Sell |
50-day EMA: | 2.25 | Sell |
200-day EMA: | 2.27 | Sell |
Aldeyra Therapeutics Earnings Growth & ALDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and a decrease next year of $0.02 per share.
Esperion Therapeutics Earnings Growth & ESPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.10 per share, an increase this year of $1.59 per share, and an increase next year of $0.62 per share.
Aldeyra Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Esperion Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |